Clincosm LogoSign in Get a demo

HODGSA: Elderly Hodgkin Lymphoma Patients Treated With Chemoradiotherapy

Sponsor
Central Hospital, Nancy, France (Other)
Overall Status
Unknown status
CT.gov ID
NCT03535948
Collaborator
(none)
90
Enrollment
2
Locations
18.6
Anticipated Duration (Months)
45
Patients Per Site
2.4
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Outcome of Hodgkin lymphoma patients over than 60 years treated by chemotherapy and/or radiotherapy: retrospective analysis.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    90 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    Outcome of Hodgkin Lymphoma Patients Over Than 60 Years Treated by Chemotherapy and/or Radiotherapy: a Retrospective Study
    Actual Study Start Date :
    May 15, 2018
    Anticipated Primary Completion Date :
    Nov 30, 2019
    Anticipated Study Completion Date :
    Dec 1, 2019

    Outcome Measures

    Primary Outcome Measures

    1. Progression-free survival [Time between diagnosis and progression or death - up to 100 weeks]

      From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    60 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Patients over than 60 years

    • Newly diagnosed Hodgkin lymphoma

    Exclusion Criteria:
    • Data not available

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 CHU Dijon Dijon France 21000
    2 CHRU Nancy Vandœuvre-lès-Nancy France 54500

    Sponsors and Collaborators

    • Central Hospital, Nancy, France

    Investigators

    • Principal Investigator: Lauriane Filliatre-Clement, CHRU Nancy

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Central Hospital, Nancy, France
    ClinicalTrials.gov Identifier:
    NCT03535948
    Other Study ID Numbers:
    • PSS2016/hodgSA-CLEMENT-F/AS
    First Posted:
    May 24, 2018
    Last Update Posted:
    Jun 17, 2019
    Last Verified:
    May 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Lymphoma
    Hodgkin Disease

    Study Results

    No Results Posted as of Jun 17, 2019